SCI Pharmtech Inc banner
S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 52.7 TWD 0.76% Market Closed
Market Cap: NT$6.3B

Balance Sheet

Balance Sheet Decomposition
SCI Pharmtech Inc

Balance Sheet
SCI Pharmtech Inc

Rotate your device to view
Balance Sheet
Currency: TWD
Dec-2003 Dec-2004 Dec-2005 Dec-2006 Dec-2007 Dec-2008 Dec-2009 Dec-2010 Dec-2011 Dec-2012 Dec-2013 Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023 Dec-2024 Dec-2025
Assets
Cash & Cash Equivalents
11
11
63
6
27
32
73
55
45
33
677
399
370
327
256
361
554
633
332
167
942
582
61
Cash
0
0
0
0
0
0
0
0
0
0
420
170
192
89
156
148
224
284
304
75
908
134
61
Cash Equivalents
11
11
63
6
27
32
73
55
45
33
257
229
178
238
100
213
330
349
28
92
34
448
0
Short-Term Investments
59
119
80
66
0
14
1
0
0
0
75
169
432
538
415
430
466
0
360
98
89
110
14
Total Receivables
108
148
105
114
229
221
194
203
206
219
216
246
171
255
174
391
352
338
349
205
308
290
249
Accounts Receivables
101
137
81
86
194
189
180
187
194
208
183
237
168
249
174
389
352
338
83
174
307
290
248
Other Receivables
7
10
24
28
35
31
14
16
12
12
34
9
3
6
0
2
0
0
266
31
0
0
1
Inventory
140
129
132
124
167
181
208
260
311
293
407
510
554
498
483
503
527
381
294
513
530
621
728
Other Current Assets
9
10
9
13
11
13
19
18
21
27
12
0
9
5
12
22
37
567
62
60
85
57
38
Total Current Assets
328
417
388
322
434
461
495
536
582
572
1 387
1 330
1 536
1 623
1 339
1 707
1 936
1 919
1 397
1 042
1 953
1 660
1 090
PP&E Net
516
471
458
545
624
671
745
829
869
937
1 555
1 776
1 785
1 762
1 786
1 884
1 880
1 503
2 100
3 194
3 912
4 803
5 137
PP&E Gross
516
471
458
545
624
671
745
829
869
937
1 555
1 776
1 785
1 762
1 786
1 884
1 880
1 503
2 100
3 194
3 912
4 803
5 137
Accumulated Depreciation
347
420
486
554
622
675
754
818
808
908
1 029
1 157
1 263
1 350
1 416
1 522
1 584
695
638
707
839
1 051
1 293
Intangible Assets
0
0
0
0
0
0
10
10
10
10
0
0
0
0
1
47
48
41
60
55
46
38
30
Long-Term Investments
0
0
0
0
0
0
0
127
35
43
30
50
42
42
42
75
137
754
125
436
470
466
415
Other Long-Term Assets
10
8
7
6
5
1
2
3
20
22
81
65
93
123
127
75
80
353
507
233
310
234
215
Total Assets
854
N/A
896
+5%
853
-5%
872
+2%
1 063
+22%
1 133
+7%
1 252
+11%
1 505
+20%
1 517
+1%
1 583
+4%
3 053
+93%
3 221
+6%
3 457
+7%
3 550
+3%
3 296
-7%
3 789
+15%
4 081
+8%
4 570
+12%
4 190
-8%
4 961
+18%
6 691
+35%
7 201
+8%
6 887
-4%
Liabilities
Accounts Payable
31
25
30
36
59
25
48
61
72
83
82
80
67
58
35
89
94
81
34
49
44
58
61
Accrued Liabilities
30
22
23
25
56
83
91
95
83
117
0
92
108
117
75
132
153
119
78
85
82
99
60
Short-Term Debt
0
58
26
19
15
22
0
175
176
35
106
50
0
0
0
0
0
0
0
112
175
0
319
Current Portion of Long-Term Debt
14
14
0
0
0
1
0
0
0
0
0
0
0
0
0
0
2
1
2
1
22
406
366
Other Current Liabilities
14
8
6
15
46
57
70
34
42
69
203
175
498
280
233
336
335
921
635
524
247
451
231
Total Current Liabilities
89
127
85
94
177
189
209
365
372
304
391
397
673
455
343
557
584
1 122
748
770
570
1 014
1 036
Long-Term Debt
14
0
0
0
0
0
0
0
0
0
563
577
0
0
0
0
1
1
1
433
846
584
303
Deferred Income Tax
0
0
1
1
0
0
0
0
0
0
0
1
0
1
1
0
0
104
104
104
146
104
105
Other Liabilities
0
2
1
0
0
1
6
8
13
17
30
21
22
23
22
22
21
20
17
25
29
21
49
Total Liabilities
103
N/A
129
+25%
86
-33%
95
+10%
177
+86%
190
+8%
214
+13%
373
+74%
385
+3%
321
-17%
985
+207%
995
+1%
695
-30%
479
-31%
366
-24%
579
+58%
607
+5%
1 248
+106%
869
-30%
1 331
+53%
1 591
+19%
1 724
+8%
1 492
-13%
Equity
Common Stock
301
325
325
325
325
362
405
453
492
493
657
697
762
795
795
795
795
795
954
954
1 195
1 195
1 195
Retained Earnings
361
354
354
364
473
495
528
553
491
608
570
682
825
937
794
1 072
1 309
1 208
1 067
1 373
1 646
2 037
1 968
Additional Paid In Capital
88
88
88
88
88
88
112
135
159
175
840
858
1 186
1 348
1 348
1 348
1 348
1 348
1 348
1 357
2 234
2 235
2 235
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
0
0
8
8
8
5
22
29
49
55
25
10
3
Other Equity
0
0
0
0
0
2
6
10
11
14
0
0
4
1
0
0
0
0
0
0
0
0
0
Total Equity
751
N/A
767
+2%
767
0%
777
+1%
886
+14%
943
+6%
1 038
+10%
1 131
+9%
1 131
N/A
1 262
+12%
2 068
+64%
2 226
+8%
2 762
+24%
3 071
+11%
2 930
-5%
3 210
+10%
3 475
+8%
3 322
-4%
3 321
0%
3 629
+9%
5 100
+41%
5 477
+7%
5 394
-2%
Total Liabilities & Equity
854
N/A
896
+5%
853
-5%
872
+2%
1 063
+22%
1 133
+7%
1 252
+11%
1 505
+20%
1 517
+1%
1 583
+4%
3 053
+93%
3 221
+6%
3 457
+7%
3 550
+3%
3 296
-7%
3 789
+15%
4 081
+8%
4 570
+12%
4 190
-8%
4 961
+18%
6 691
+35%
7 201
+8%
6 887
-4%
Shares Outstanding
Common Shares Outstanding
55
55
55
55
55
56
57
58
58
58
69
70
76
95
95
95
95
109
109
109
120
120
120
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett